A facile synthesis and the antimicrobial activity of some 4-aryltriazoles

被引：4

作者：

Baluja, Shipra ^{[1
]}

Chanda, Sumitra

Chabhadiya, Rajesh

Kachhadia, Nikunj

Nair, Rathish

Solanki, Asif

机构：

[1] Saurashtra Univ, Dept Chem, Rajkot 360005, Gujarat, India

[2] Saurashtra Univ, Dept Biosci, Rajkot 360005, Gujarat, India

来源：

JOURNAL OF THE SERBIAN CHEMICAL SOCIETY | 2007年 / 72卷 / 06期

关键词：

4-aryltriazoles; synthesis; antibacterial activity;

D O I：

10.2298/JSC0706539B

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Some 4-aryltriazoles were synthesized and tested for their antibacterial effects against Bacillus cereus, Pseudomonas testosteroni, Klebsiella pneumoniae Micrococcus flavus, and Citrobacter freundii. The 4-aryltriazoles were obtained by cyclization of the potassium salt of the appropriately substituted dithiocarbazinic acid with aromatic amines. The new synthesized compounds were characterized using infrared and H-1 nuclear magnetic resonance spectroscopy and further supported by mass spectrometry.

引用

页码：539 / 544

页数：6

共 19 条

[1] Fluorosulfonyl- and bis-(β-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives:: Irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies [J].

Baraldi, PG ;

Cacciari, B ;

Moro, S ;

Romagnoli, R ;

Ji, XD ;

Jacobson, KA ;

Gessi, S ;

Borea, PA ;

Spalluto, G .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) :2735-2742

[2]

CHAMBERS MS, 2002, Patent No. 0242305

[3]

Crisan O., 2001, FARMACIA, V49, P15

[4]

GALABOV AS, 1991, J MED CHEM SOC, V68, P110

[5]

HAZZAA AAB, 1983, ARCH PHARM CHEMI SCI, V11, P43

[6] Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles [J].

Holla, BS ;

Veerendra, B ;

Shivananda, MK ;

Poojary, B .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (7-8) :759-767

[7]

Holla BS, 2002, INDIAN J CHEM B, V41, P1257

[8]

IMMA H, 2002, Patent No. 0368776

[9]

KHAUNUM SA, 2003, SCI ASIA, V29, P383

[10]

Labanauskas L., 2004, Farmaco (Lausanne), V59, P255, DOI 10.1016/j.farmac.2003.11.002

← 1 2 →